Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin
96%
Angiotensin II
75%
Frailty
62%
Receptor
60%
Renin
51%
Valsartan
42%
Inflammation
42%
Mouse
35%
Diabetes Mellitus
35%
Angiotensin 2 Receptor
33%
Wound Healing
31%
Chronic Wound
27%
Angiotensin Receptor
27%
Wound
26%
Chronic Inflammation
24%
Losartan
23%
Tumor Necrosis Factor
22%
Angiotensin 1 Receptor
19%
Knockout Mouse
19%
Bradykinin B2 Receptor
19%
Mouse Model
16%
Cardiovascular Disease
15%
Interleukin 6
12%
Angiotensin Receptor Antagonist
11%
Biological Marker
10%
Prostaglandin E2
9%
Nitric Oxide
9%
Acute Lung Injury
9%
Autoantibodies
9%
Macrophage Migration Inhibition Factor
9%
Cardiomyopathy
9%
Synapsin II
9%
Cell Penetrating Peptide
9%
STAT Protein
9%
Mitochondrial DNA
9%
Protein X
9%
Sacubitril
9%
Genomic DNA
9%
Adverse Outcome
9%
Kynurenine
9%
Malignant Neoplasm
9%
Interleukin 10
9%
Nanoparticle
9%
Metformin
9%
Receptor Blocking Agent
7%
Alzheimer's Disease
7%
Wild Type Mouse
7%
1 (4 Dimethylamino 3 Methylbenzyl) 5 Diphenylacetyl 4,5,6,7 Tetrahydro 1h imidazo[4,5 C]pyridine 6 Carboxylic Acid
7%
Cognitive Defect
6%
Migration Inhibition Factor
6%
Keyphrases
Older Adults
73%
Angiotensin II Type 1 Receptor (AT1R)
58%
Renin-angiotensin System
42%
Aging
40%
Frailty
39%
Chronic Inflammation
35%
Angiotensin
34%
Chronic Wounds
28%
Inflammation
28%
AT2R
26%
Losartan
26%
Mouse Model
23%
Interleukin-6
23%
Interleukin-10
23%
Oxidative Stress
23%
American Geriatrics Society
22%
2 Receptor
20%
Wound Healing
19%
Null Mice
19%
Wound Repair
19%
Physical Frailty
18%
Angiotensin Receptor Blockers
18%
Physical Function
17%
Age-related
17%
National Institute on Aging
17%
Geriatrics
16%
Age-related Illnesses
15%
Physical Decline
14%
Valsartan
14%
Mitochondrial Dysfunction
13%
Kynurenine
13%
Cognitive Function
12%
Older Individuals
12%
Skeletal muscle
12%
Angiotensin Type I Receptor
12%
Cardiovascular Disease
12%
Physical Outcomes
11%
Cognitive Frailty
11%
Age-related Changes
11%
Functional Decline
11%
Inflammatory Markers
11%
Physical Performance
10%
Low Sodium Intake
10%
Grip Strength
10%
Artificial Technology
9%
Macrophage Inhibitory Factor
9%
Bedside to Bench
9%
Community-dwelling Older Adults
9%
Nature-inspired
9%
Phosphorylation
9%
Neuroscience
Angiotensin
100%
Renin
61%
Angiotensin II Receptor Type 1
56%
Angiotensin Receptor
53%
Eicosanoid Receptor
42%
Losartan
39%
Oxidative Stress
38%
Alzheimer's Disease
38%
Angiotensin II
33%
Angiotensin II Receptor Type 2
26%
Interleukin 6
22%
Lisinopril
19%
Mitochondrial DNA
17%
Skeletal Muscle
17%
Mitochondrion
16%
Placebo
15%
Cognitive Disorders
15%
ACE Inhibitor
14%
Drosophila Melanogaster
11%
Prostaglandin E2
9%
Diabetes Mellitus
9%
STAT Protein
9%
Protein X
9%
Synapsin II
9%
Longitudinal Study
9%
Cardiomyopathy
9%
Genomic Signature
9%
Kynurenine
9%
Autoantibodies
9%
Macrophage Migration Inhibition Factor
9%
Bradykinin Receptor B2
9%
Tumor Necrosis Factor Receptor 1
9%
Interleukin 10
9%
Corticosterone
9%
Cell Signaling
9%
Frontal Lobe
8%
Reactive Oxygen Species
8%
Free Radical
8%
Gene Dosage
8%
Receptor Subtype
7%
Necrosis
7%
Amyloid
7%
Migration Inhibition Factor
6%
Antioxidant
6%
Prostaglandin F2
6%
Energy Transfer
6%
Dipeptidyl Carboxypeptidase
5%
Telomere
5%
Phosphoprotein
5%
